The incremental burden and healthcare resource utilization among people with migraine in Europe: Insights from the 2020 European National Health and Wellness Survey
Migraine sufferers with ≥1 migraine headache days experienced worse productivity, lower quality of life, depression, and increased healthcare resource utilization than those without migraine, emphasizing the need for effective management strategies.
Authors
- Gianluca Coppola (ORCID: https://orcid.org/0000-0002-8510-6925)
- Sheila Drakeley (ORCID: https://orcid.org/0000-0002-3779-2377)
- Karin Hygge Blakeman (ORCID: https://orcid.org/0000-0001-6925-7099)
- Astrid Gendolla (ORCID: https://orcid.org/0000-0002-9884-3158)
- Joshua David Brown (ORCID: https://orcid.org/0000-0002-2973-1021)
- Aaron Jenkins (ORCID: https://orcid.org/0000-0001-9785-9388)
- Amanda R. Mercadante
- Nikoletta Sternbach (ORCID: https://orcid.org/0000-0001-5784-8254)
Institutions
- Oracle (United States) (US)
- Pfizer (United States) (US)
- Pfizer (United Kingdom) (GB)
- Pfizer (Sweden) (SE)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Cephalalgia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1177/03331024241276415
- Citations
- 5
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.93
Funders
- Pfizer